U.S. FDA Advisers Back Pfizer/BioNTech COVID-19 Vaccine For Children 2021
A specialist board on Tuesday casted a ballot predominantly to suggest the U.S. Food and Drug Administration approve the Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) COVID-19 antibody for kids ages 5 to 11, saying the advantages of vaccination offset the dangers. An approval for that age gathering would be would be a significant administrative …
U.S. FDA Advisers Back Pfizer/BioNTech COVID-19 Vaccine For Children 2021 Read More »